Allergic contact dermatitis caused by isobornyl acrylate in a young diabetic patient using a continous glucose monitoring system (Freestyle Libre)

2018 ◽  
Vol 79 (5) ◽  
pp. 320-321 ◽  
Author(s):  
Monica Corazza ◽  
Valeria Scuderi ◽  
Dario Musmeci ◽  
Caterina Foti ◽  
Paolo Romita ◽  
...  

2018 ◽  
Vol 12 (3) ◽  
pp. 630-633 ◽  
Author(s):  
Stefanie Kamann ◽  
Olivier Aerts ◽  
Lutz Heinemann

In the past decade, new diabetes technologies, including continuous glucose monitoring (CGM) systems, support patients with diabetes in their daily struggle with achieving a good glucose control. However, shortly after the first CGM systems appeared on the market, also the first concerns about adverse skin reactions were raised. Most patients claimed to suffer from (sometimes severe) skin irritation, or even allergy, which they related to the (acrylate-based) adhesive part of the device. For a long time the actual substance that caused these skin reactions with, for example, the Flash Glucose Monitoring system (iscCGM; Freestyle® Libre) could not be identified; however, recently Belgian and Swedish dermatologists reported that the majority of their patients that have developed a contact-allergic while using iscCGM react sensitively to a specific acrylate, that is, isobornyl acrylate (IBOA). Subsequently they showed by means of gas chromatography-mass spectrometry that this substance is present in the case of the glucose sensor attached by an adhesive to the skin. We report three additional cases from Germany, including a 10-year-old boy, suffering from severe allergic contact dermatitis to IBOA.



2019 ◽  
Vol 14 (3) ◽  
pp. 582-585 ◽  
Author(s):  
Stefanie Kamann ◽  
Lutz Heinemann ◽  
Eva Oppel

Background: Continuous glucose monitoring (CGM) systems replace more and more capillary self-monitoring of blood glucose by patients with diabetes. However, at least a subset of patients experience adverse skin reactions such as severe allergic contact dermatitis (ACD) after prolonged usage of CGM systems. A major allergen isobornyl acrylate (IBOA) has been identified recently. Objectives: After developing an ACD, patients have difficulties in continuing the usage of their CGM system (and also of, eg, certain patch pumps). Most of such patients look for possibilities to continue the usage of, eg, a CGM system that requires intermittent scanning (iscCGM, Freestyle Libre). Patients and Methods: Eight patients with a known ACD were supplied with different hydrocolloid-based plasters ( n = 5 with Hansaplast blister plaster, n = 2 with Cutimed Hydro B from BSN, and n = 1 with Stomahesive baseplate from Convatec). They attached these plasters to their skin underneath their iscCGM system. Results: All patients were able to continue the usage of this iscCGM system when using such plasters. Conclusion: Patients with ACD benefit from the usage of such plasters; however, some limitations have to be acknowledged.



2021 ◽  
Author(s):  
María‐Elena Gatica‐Ortega ◽  
María‐Antonia Pastor‐Nieto ◽  
Rafaela Torres‐Aranda ◽  
Loreto Luna‐Bastante ◽  
Cristina Pérez‐Hortet


2019 ◽  
Vol 81 (6) ◽  
pp. 456-458 ◽  
Author(s):  
Anne Herman ◽  
Laurence Montjoye ◽  
Liliane Marot ◽  
Marie Baeck


2019 ◽  
Vol 81 (3) ◽  
pp. 219-220 ◽  
Author(s):  
Ignacio Jáuregui ◽  
Javier Sánchez ◽  
Aritza Segurola ◽  
Cristina Galán ◽  
Yolanda Seras ◽  
...  


2020 ◽  
Vol 83 (2) ◽  
pp. 154-157
Author(s):  
Catarina S. Queirós ◽  
Maria I. Alexandre ◽  
Pedro M. Garrido ◽  
Teresa E. Correia ◽  
Paulo L. Filipe




2020 ◽  
Vol 78 (4) ◽  
pp. 381-384
Author(s):  
C. S. Queirós ◽  
M. I. Alexandre ◽  
P. M. Garrido ◽  
L. Soares de Almeida ◽  
T. Correia ◽  
...  

In the past few years, the glucose sensor FreeStyle Libre® has been associated with several cases of allergic contact dermatitis. The allergen responsible for most of these cases is isobornyl acrylate, a substance present within the sensor that migrates through the adhesive, thereby reaching the skin. Acquired leukoderma, which may occur in an area previously affected by allergic contact dermatitis, has been described in several medical devices with adhesives. However, until the present, only one case of leukoderma induced by allergic contact dermatitis to FreeStyle Libre® has been described. We report the case of a 41-year-old woman with diabetes mellitus type 1, who developed leukoderma in association with allergic contact dermatitis to this glucose sensor.



Sign in / Sign up

Export Citation Format

Share Document